Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad) Buy CMRX Stock  Free CMRX Stock Alerts

Chimerix (CMRX) Financials

Chimerix logo
$8.54 0.00 (0.00%)
As of 04/21/2025
Compare
Annual Income Statements for Chimerix

Annual Income Statements for Chimerix

This table shows Chimerix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 -88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Consolidated Net Income / (Loss)		 -88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Net Income / (Loss) Continuing Operations		 -88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Total Pre-Tax Income 		-88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Total Operating Income		 -97 -93 -60 -173 -45 -116 -72 -72 -78 -118 -59
Total Gross Profit		 0.21 0.32 33 1.98 5.37 13 7.22 4.49 5.70 11 4.04
Total Revenue		 0.21 0.32 34 1.98 5.37 13 7.22 4.49 5.70 11 4.04
Operating Revenue		 0.21 0.32 34 1.98 5.37 13 7.22 4.49 5.70 11 4.04
Total Cost of Revenue		 0.00 0.00 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cost of Revenue		 0.00 0.00 0.45 0.00 0.00 - - - - - -
Total Operating Expenses		 97 93 94 175 50 129 79 77 84 129 63
Selling, General & Admin Expense		 22 25 22 19 14 21 24 27 25 31 18
Research & Development Expense		 75 69 72 157 36 107 55 49 59 98 45
Total Other Income / (Expense), net		 8.18 11 233 0.16 0.99 3.41 2.13 1.12 1.56 0.88 -0.45
Interest Expense		 -8.18 -11 -2.92 -0.16 -0.99 -3.41 -2.13 -1.12 -1.56 -0.88 0.45
Other Income / (Expense), net		 0.00 0.00 230 0.00 0.00 - - - 0.00 0.00 -
Income Tax Expense		 0.00 0.00 0.04 0.00 0.00 - - - - - -
Basic Earnings per Share		 ($0.99) ($0.93) $1.97 ($2.04) ($0.70) ($2.03) ($1.43) ($1.51) ($1.65) ($2.67) ($1.80)
Weighted Average Basic Shares Outstanding		 89.70M 88.60M 87.56M 84.93M 62.18M 55.50M 48.59M 46.96M 46.27M 43.88M 33.00M
Diluted Earnings per Share		 ($0.99) ($0.93) $1.94 ($2.04) ($0.70) ($2.03) ($1.43) ($1.51) ($1.65) ($2.67) ($1.80)
Weighted Average Diluted Shares Outstanding		 89.70M 88.60M 88.78M 84.93M 62.18M 55.50M 48.59M 46.96M 46.27M 43.88M 33.00M
Weighted Average Basic & Diluted Shares Outstanding		 93.80M 89.21M 88.27M 87.03M 62.18M 55.50M 48.59M 46.96M 46.27M 43.88M 33.00M

Quarterly Income Statements for Chimerix

This table shows Chimerix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -23 -23 -21 -22 -18 -24 -19 -21 -21 241
Consolidated Net Income / (Loss)		 -23 -23 -21 -22 -18 -24 -19 -21 -21 241
Net Income / (Loss) Continuing Operations		 -23 -23 -21 -22 -18 -24 -19 -21 -21 241
Total Pre-Tax Income 		-23 -23 -21 -22 -18 -24 -19 -21 -21 242
Total Operating Income		 -25 -25 -23 -24 -21 -27 -21 -24 -24 12
Total Gross Profit		 0.06 0.03 0.13 0.00 0.00 0.01 0.03 0.28 0.81 32
Total Revenue		 0.06 0.03 0.13 0.00 0.00 0.01 0.03 0.28 0.81 33
Operating Revenue		 0.06 0.03 0.13 0.00 0.00 0.01 0.03 0.28 0.81 33
Total Operating Expenses		 25 25 23 24 21 27 21 25 25 21
Selling, General & Admin Expense		 6.95 5.17 4.53 5.55 5.17 9.30 4.45 5.68 5.35 5.31
Research & Development Expense		 18 20 18 19 16 17 17 19 19 15
Total Other Income / (Expense), net		 1.60 1.91 2.15 2.52 2.65 2.70 2.77 2.85 2.74 230
Interest Expense		 -1.60 -1.91 -2.15 -2.52 -2.65 -2.70 -2.77 -2.85 -2.74 -0.20
Basic Earnings per Share		 ($0.25) ($0.26) ($0.23) ($0.25) ($0.21) ($0.27) ($0.21) ($0.24) ($0.23) $2.75
Weighted Average Basic Shares Outstanding		 89.70M 89.70M 89.63M 89.26M 88.60M 88.62M 88.58M 88.29M 87.56M 87.63M
Diluted Earnings per Share		 ($0.25) ($0.26) ($0.23) ($0.25) ($0.21) ($0.27) ($0.21) ($0.24) ($0.26) $2.75
Weighted Average Diluted Shares Outstanding		 89.70M 89.70M 89.63M 89.26M 88.60M 88.62M 88.58M 88.29M 88.78M 87.81M
Weighted Average Basic & Diluted Shares Outstanding		 93.80M 89.94M 89.64M 89.63M 89.21M 88.89M 88.58M 88.58M 88.27M 88.05M

Annual Cash Flow Statements for Chimerix

This table details how cash moves in and out of Chimerix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 3.39 1.82 10 -32 30 -64 63 -33 31 -108 18
Net Cash From Operating Activities		 -75 -69 -47 -100 -36 -75 -54 -50 -64 -100 -47
Net Cash From Continuing Operating Activities		 -75 -69 -47 -100 -36 -75 -54 -50 -64 -100 -47
Net Income / (Loss) Continuing Operations		 -88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Consolidated Net Income / (Loss)		 -88 -82 172 -173 -44 -113 -69 -71 -76 -117 -59
Depreciation Expense		 0.09 0.09 0.10 0.17 0.40 0.56 0.86 1.09 1.06 0.66 0.28
Amortization Expense		 -3.47 -6.96 -1.32 1.15 -0.20 -1.92 -0.85 -0.01 1.22 1.69 1.32
Non-Cash Adjustments To Reconcile Net Income		 9.47 17 -214 70 5.55 45 14 17 16 13 4.41
Changes in Operating Assets and Liabilities, net		 7.44 2.42 -3.42 2.29 1.73 -5.97 1.94 2.49 -5.93 2.36 6.22
Net Cash From Investing Activities		 71 71 70 -44 65 11 105 16 94 -169 -160
Net Cash From Continuing Investing Activities		 71 71 70 -44 65 11 105 16 94 -169 -160
Purchase of Property, Plant & Equipment		 -0.29 -0.09 -0.07 -0.21 -0.06 -0.16 -0.18 -0.15 -0.84 -2.39 -1.02
Purchase of Investments		 -131 -129 -241 -115 -74 -168 -132 -163 -103 -295 -211
Sale of Property, Plant & Equipment		 0.00 0.01 0.00 0.00 0.01 0.00 0.00 - - - -
Divestitures		 0.00 0.00 234 0.00 0.00 - - - - - -
Sale and/or Maturity of Investments		 203 199 77 71 139 178 237 179 198 128 52
Net Cash From Financing Activities		 7.05 0.31 -13 112 1.41 0.35 11 0.78 0.61 161 225
Net Cash From Continuing Financing Activities		 7.05 0.31 -13 112 1.41 0.35 11 0.78 0.61 161 225
Repayment of Debt		 -0.40 -0.16 -14 0.00 0.00 - - - - -4.69 -5.70
Issuance of Common Equity		 7.44 0.47 0.86 109 0.43 0.33 11 0.71 0.44 163 226
Other Financing Activities, net		 0.01 0.00 0.61 3.83 0.99 0.04 0.12 0.12 0.17 3.11 4.60

Quarterly Cash Flow Statements for Chimerix

This table details how cash moves in and out of Chimerix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 7.40 7.99 -3.37 -8.64 14 -5.98 4.15 -9.89 -248 246
Net Cash From Operating Activities		 -19 -21 -18 -18 -15 -18 -14 -22 -20 7.13
Net Cash From Continuing Operating Activities		 -19 -21 -18 -17 -15 -18 -14 -22 -20 7.13
Net Income / (Loss) Continuing Operations		 -23 -23 -21 -22 -18 -24 -19 -21 -21 241
Consolidated Net Income / (Loss)		 -23 -23 -21 -22 -18 -24 -19 -21 -21 241
Depreciation Expense		 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03
Amortization Expense		 -0.44 -0.79 -1.13 -1.12 -1.44 -1.61 -1.86 -2.05 -1.60 0.06
Non-Cash Adjustments To Reconcile Net Income		 2.14 2.38 2.19 2.75 2.25 7.88 2.96 4.36 4.17 -226
Changes in Operating Assets and Liabilities, net		 2.07 0.75 1.89 2.72 2.74 -0.24 3.11 -3.19 -1.62 -8.47
Net Cash From Investing Activities		 20 28 14 8.68 28 12 19 12 -228 238
Net Cash From Continuing Investing Activities		 20 28 14 8.68 28 12 19 12 -228 238
Purchase of Property, Plant & Equipment		 -0.16 -0.03 -0.07 -0.03 - -0.02 -0.01 -0.06 0.00 -0.07
Purchase of Investments		 -36 -30 -24 -41 -32 -51 -39 -6.80 -230 -6.05
Sale and/or Maturity of Investments		 56 58 39 50 60 63 57 19 1.35 10
Net Cash From Financing Activities		 6.71 0.18 -0.04 0.21 0.06 0.08 -0.03 0.20 -0.03 0.78
Net Cash From Continuing Financing Activities		 6.71 0.18 -0.04 0.21 0.06 0.08 -0.03 0.20 -0.03 0.78
Repayment of Debt		 -0.14 -0.04 -0.04 -0.17 0.06 -0.03 -0.03 -0.16 -0.19 -
Issuance of Common Equity		 6.84 0.22 - 0.38 - 0.11 - 0.36 - 0.30
Other Financing Activities, net		 0.01 - - - - - - - - 0.51

Annual Balance Sheets for Chimerix

This table presents Chimerix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 146 213 279 101 85 119 191 235 287 356 292
Total Current Assets		 136 189 228 96 82 118 189 157 236 229 237
Cash & Equivalents		 31 28 26 15 47 17 81 19 51 21 128
Short-Term Investments		 101 155 191 73 32 97 105 133 181 200 106
Accounts Receivable		 0.06 0.00 1.04 0.00 0.34 1.23 0.33 1.68 1.60 2.43 0.11
Prepaid Expenses		 4.25 6.27 9.76 4.68 2.36 3.39 2.60 3.33 2.85 6.07 2.78
Plant, Property, & Equipment, net		 0.42 0.22 0.23 0.25 0.21 0.54 1.21 1.89 2.84 3.05 1.31
Total Noncurrent Assets		 9.64 23 51 4.48 2.85 0.74 0.05 77 47 124 53
Long-Term Investments		 8.48 22 49 2.02 0.00 - - 77 47 124 53
Other Noncurrent Operating Assets		 1.17 1.78 2.35 2.46 2.85 0.74 0.05 0.07 0.06 0.07 0.14
Total Liabilities & Shareholders' Equity		 146 213 279 101 85 119 191 235 287 356 292
Total Liabilities		 24 20 22 32 11 9.42 13 13 11 21 17
Total Current Liabilities		 24 18 20 30 8.53 9.23 13 13 10 20 17
Accounts Payable		 3.94 2.85 3.03 2.79 1.28 2.40 4.69 3.81 3.89 10 5.94
Accrued Expenses		 20 16 17 13 7.25 6.83 8.28 9.38 6.22 9.72 6.83
Total Noncurrent Liabilities		 0.46 1.30 2.07 2.39 2.81 0.20 0.14 0.22 0.44 0.35 0.18
Other Noncurrent Operating Liabilities		 0.46 1.30 2.07 2.39 2.81 0.20 0.14 0.22 0.44 - 0.18
Total Equity & Noncontrolling Interests		 122 193 257 68 73 110 178 222 276 335 275
Total Preferred & Common Equity		 122 193 257 68 73 110 178 222 276 335 275
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 122 193 257 68 73 110 178 222 276 335 275
Common Stock		 1,006 989 971 954 786 779 734 710 692 676 497
Retained Earnings		 -884 -796 -713 -886 -712 -669 -556 -487 -416 -339 -222
Accumulated Other Comprehensive Income / (Loss)		 0.02 0.01 -0.34 -0.02 0.00 0.04 -0.09 -0.96 -0.44 -0.76 0.04

Quarterly Balance Sheets for Chimerix

This table presents Chimerix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 159 179 194 225 241 259 294
Total Current Assets		 141 153 163 201 212 225 291
Cash & Equivalents		 24 16 19 14 20 16 274
Short-Term Investments		 113 133 140 180 186 199 10
Accounts Receivable		 0.16 0.13 0.00 0.01 0.03 0.67 0.47
Prepaid Expenses		 4.52 5.16 4.00 6.14 5.74 9.33 6.02
Plant, Property, & Equipment, net		 0.28 0.28 0.26 0.25 0.26 0.27 0.25
Total Noncurrent Assets		 17 25 31 24 29 34 2.51
Long-Term Investments		 16 23 29 23 27 31 0.00
Other Noncurrent Operating Assets		 1.28 1.47 1.61 1.90 2.05 2.19 2.51
Total Liabilities & Shareholders' Equity		 159 179 194 225 241 259 294
Total Liabilities		 23 23 20 17 17 18 20
Total Current Liabilities		 22 22 19 16 15 16 18
Accounts Payable		 5.34 4.16 3.82 2.50 1.82 2.85 3.28
Accrued Expenses		 17 18 15 13 14 14 14
Total Noncurrent Liabilities		 0.64 0.83 1.01 1.47 1.63 1.79 2.22
Other Noncurrent Operating Liabilities		 0.64 0.83 1.01 1.47 1.63 1.79 1.97
Total Equity & Noncontrolling Interests		 136 156 174 208 224 240 274
Total Preferred & Common Equity		 136 156 174 208 224 240 274
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 136 156 174 208 224 240 274
Common Stock		 996 994 992 986 978 975 966
Retained Earnings		 -861 -838 -817 -777 -753 -735 -692
Accumulated Other Comprehensive Income / (Loss)		 0.26 -0.21 -0.18 -0.63 -0.81 -0.23 -0.04

Annual Metrics And Ratios for Chimerix

This table displays calculated financial ratios and metrics derived from Chimerix's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -34.57% -99.04% 1,609.15% -63.16% -57.09% 73.49% 60.57% -21.19% -47.02% 166.39% -7.55%
EBITDA Growth		 -0.02% -159.46% 197.66% -288.30% 62.23% -63.89% -0.82% 6.15% 34.72% -102.42% -65.99%
EBIT Growth		 -3.76% -154.98% 197.63% -289.52% 61.62% -61.98% 0.69% 7.50% 34.08% -100.88% -67.19%
NOPAT Growth		 -3.76% -7.90% 50.26% -289.52% 61.62% -61.98% 0.69% 7.50% 34.08% -100.88% -105.69%
Net Income Growth		 -7.66% -147.68% 199.38% -298.04% 61.34% -62.04% 2.13% 7.08% 34.92% -97.89% -62.74%
EPS Growth		 -6.45% -147.94% 195.10% -191.43% 65.52% -41.96% 5.30% 8.48% 38.20% -48.33% 50.68%
Operating Cash Flow Growth		 -8.52% -47.41% 53.10% -177.29% 52.07% -39.94% -7.18% 21.45% 36.00% -111.80% -84.19%
Free Cash Flow Firm Growth		 3.45% -5.69% 50.01% -308.37% 66.40% -81.77% -0.86% 21.64% 26.92% -141.45% 7.11%
Invested Capital Growth		 -60.86% -25.93% -11.87% -45.67% -58.56% 60.53% -38.58% -101.03% 64.06% -3.46% -448.85%
Revenue Q/Q Growth		 33.33% -71.43% 2.32% -35.18% -51.25% 17.93% 71.97% -2.94% -16.54% 22.18% 7.36%
EBITDA Q/Q Growth		 -2.91% 3.07% 322.46% -19.24% -20.33% 8.96% 3.85% -5.34% 23.07% -18.29% -25.76%
EBIT Q/Q Growth		 -4.03% 3.13% 322.44% -19.07% -21.52% 9.05% 4.36% -4.82% 22.67% -17.95% -26.27%
NOPAT Q/Q Growth		 -4.03% 3.13% 20.67% -19.07% -21.52% 9.05% 4.36% -4.82% 22.67% -17.95% -26.27%
Net Income Q/Q Growth		 -5.73% 3.30% 12.07% -19.13% -23.12% 9.23% 5.81% -6.42% 23.05% -17.63% -25.56%
EPS Q/Q Growth		 -4.21% 5.10% 8.38% -12.09% -20.69% 9.78% 7.14% -5.59% 23.96% -12.18% -109.55%
Operating Cash Flow Q/Q Growth		 -6.66% 7.25% 23.05% -33.33% -18.30% 6.04% 6.64% -5.09% 26.68% -19.18% -27.27%
Free Cash Flow Firm Q/Q Growth		 -6.33% 8.99% 17.12% -18.21% -12.73% 3.01% 8.16% -2.60% 22.86% -23.18% -5.69%
Invested Capital Q/Q Growth		 -10.74% -31.97% 12.71% -35.46% -21.54% 26.10% -86.81% -51.91% -50.85% 8.09% -32.98%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 98.68% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -47,143.87% -30,842.59% 496.86% -8,695.60% -824.98% -937.27% -992.20% -1,580.24% -1,327.01% -1,077.01% -1,417.33%
Operating Margin		 -45,550.47% -28,723.77% -178.53% -8,762.00% -828.67% -926.46% -992.31% -1,604.41% -1,367.10% -1,098.78% -1,457.08%
EBIT Margin		 -45,550.47% -28,723.77% 500.48% -8,762.00% -828.67% -926.46% -992.31% -1,604.41% -1,367.10% -1,098.78% -1,457.08%
Profit (Net Income) Margin		 -41,691.98% -25,337.96% 509.01% -8,753.71% -810.16% -899.24% -962.78% -1,579.53% -1,339.71% -1,090.62% -1,468.12%
Tax Burden Percent		 100.00% 100.00% 99.98% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 91.53% 88.21% 101.72% 99.91% 97.77% 97.06% 97.02% 98.45% 98.00% 99.26% 100.76%
Effective Tax Rate		 0.00% 0.00% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -56.17% -36.50% 105.91% -244.64% -47.48% -78.30% -34.79% -28.51% -24.98% -38.48% -31.79%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -53.83% -37.82% 89.12% -187.19% -43.62% -74.81% -33.62% -27.63% -24.26% -36.50% -29.05%
Return on Assets (ROA)		 -49.27% -33.36% 90.64% -187.02% -42.65% -72.61% -32.62% -27.20% -23.77% -36.23% -29.27%
Return on Common Equity (ROCE)		 -56.17% -36.50% 105.91% -244.64% -47.48% -78.30% -34.79% -28.51% -24.98% -38.48% -31.79%
Return on Equity Simple (ROE_SIMPLE)		 -72.64% -42.53% 67.03% -253.82% -59.31% -102.39% -39.12% -32.00% -27.66% -34.99% -21.60%
Net Operating Profit after Tax (NOPAT)		 -68 -65 -60 -121 -31 -81 -50 -50 -55 -83 -41
NOPAT Margin		 -31,885.33% -20,106.64% -178.49% -6,133.40% -580.07% -648.52% -694.62% -1,123.08% -956.97% -769.15% -1,019.96%
Net Nonoperating Expense Percent (NNEP)		 -12.07% -7.21% 135.85% -66.76% -12.85% -20.92% -9.33% -8.08% -7.00% -11.02% -9.45%
Return On Investment Capital (ROIC_SIMPLE)		 -55.55% -33.75% -23.50% - - - - - - - -
Cost of Revenue to Revenue		 0.00% 0.00% 1.32% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 10,474.06% 7,592.90% 65.43% 943.51% 254.21% 169.10% 326.80% 604.09% 438.57% 290.80% 433.84%
R&D to Revenue		 35,176.42% 21,230.86% 211.78% 7,918.49% 674.46% 857.36% 765.51% 1,100.31% 1,028.53% 907.98% 1,123.24%
Operating Expenses to Revenue		 45,650.47% 28,823.77% 277.21% 8,862.00% 928.67% 1,026.46% 1,092.31% 1,704.41% 1,467.10% 1,198.78% 1,557.08%
Earnings before Interest and Taxes (EBIT)		 -97 -93 169 -173 -45 -116 -72 -72 -78 -118 -59
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -100 -100 168 -172 -44 -117 -72 -71 -76 -116 -57
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.57 0.44 0.64 8.18 4.12 1.13 0.73 0.98 0.77 1.23 5.35
Price to Tangible Book Value (P/TBV)		 2.57 0.44 0.64 8.18 4.12 1.13 0.73 0.98 0.77 1.23 5.35
Price to Revenue (P/Rev)		 1,476.31 264.07 4.84 282.23 56.31 9.95 18.07 48.55 37.36 38.38 363.49
Price to Earnings (P/E)		 0.00 0.00 0.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 105.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 815.37 0.00 0.00 243.63 41.62 0.89 0.00 0.00 0.00 6.38 293.38
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.02
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.10 -1.05 -1.05 -1.10 -1.05 -1.04 -1.04 -1.02 -1.02 -1.03 -1.03
Leverage Ratio		 1.14 1.09 1.17 1.31 1.11 1.08 1.07 1.05 1.05 1.06 1.09
Compound Leverage Factor		 1.04 0.96 1.19 1.31 1.09 1.05 1.03 1.03 1.03 1.05 1.09
Debt to Total Capital		 0.00% 0.00% 0.00% 17.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.54%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 17.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.54%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 82.98% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.46%
Debt to EBITDA		 0.00 0.00 0.00 -0.08 0.00 0.00 0.00 0.00 0.00 0.00 -0.08
Net Debt to EBITDA		 0.00 0.00 0.00 0.44 0.00 0.00 0.00 0.00 0.00 0.00 4.95
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 -0.12 0.00 0.00 0.00 0.00 0.00 0.00 -0.10
Net Debt to NOPAT		 0.00 0.00 0.00 0.63 0.00 0.00 0.00 0.00 0.00 0.00 6.87
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -2.02 -3.11 3.81 -6.84 3.59 -1.92 1.79 6.60 10.16 10.37 50.29
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.70 10.25 11.18 3.20 9.57 12.80 14.61 11.86 23.40 11.34 13.91
Quick Ratio		 5.52 9.91 10.70 2.96 9.29 12.43 14.41 11.61 23.12 11.04 13.75
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -61 -63 -59 -119 -29 -87 -48 -47 -60 -82 -34
Operating Cash Flow to CapEx		 -26,124.39% -85,293.83% -66,009.86% -48,275.36% -75,079.17% -47,582.91% -29,682.32% -33,195.36% -7,587.99% -4,166.65% -4,624.46%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -76.59
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -105.55
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -107.84
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.18 0.02 0.05 0.08 0.03 0.02 0.02 0.03 0.02
Accounts Receivable Turnover		 6.95 0.62 0.00 0.00 6.83 16.02 7.17 2.74 2.83 8.48 22.82
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.66 1.44 140.93 8.48 14.25 14.31 4.65 1.90 1.94 4.94 4.90
Accounts Payable Turnover		 0.00 0.00 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 52.51 588.06 0.00 0.00 53.44 22.79 50.89 133.24 129.02 43.04 15.99
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 2,376.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 52.51 588.06 -2,376.99 0.00 53.44 22.79 50.89 133.24 129.02 43.04 15.99
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -18 -11 -9.10 -8.14 -5.59 -3.52 -8.93 -6.44 -3.20 -8.92 -8.62
Invested Capital Turnover		 -0.01 -0.03 -3.92 -0.29 -1.18 -2.01 -0.94 -0.93 -0.94 -1.23 -0.79
Increase / (Decrease) in Invested Capital		 -6.98 -2.36 -0.97 -2.55 -2.06 5.40 -2.49 -3.24 5.71 -0.30 -7.05
Enterprise Value (EV)		 173 -119 -102 482 224 11 -56 -10 -66 69 1,185
Market Capitalization		 313 86 164 559 303 125 130 218 213 413 1,469
Book Value per Share		 $1.35 $2.17 $2.92 $0.79 $1.17 $1.79 $3.50 $4.71 $5.96 $7.27 $7.53
Tangible Book Value per Share		 $1.35 $2.17 $2.92 $0.79 $1.17 $1.79 $3.50 $4.71 $5.96 $7.27 $7.53
Total Capital		 122 193 257 82 73 110 178 222 276 335 279
Total Debt		 0.00 0.00 0.00 14 0.00 0.00 0.00 0.00 0.00 0.00 4.30
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -140 -204 -266 -76 -79 -113 -187 -228 -279 -344 -283
Capital Expenditures (CapEx)		 0.29 0.08 0.07 0.21 0.05 0.16 0.18 0.15 0.84 2.39 1.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -20 -12 -9.61 -8.46 -5.84 -4.61 -10 -8.18 -5.66 -12 -9.89
Debt-free Net Working Capital (DFNWC)		 112 171 208 80 73 109 176 143 226 209 225
Net Working Capital (NWC)		 112 171 208 66 73 109 176 143 226 209 220
Net Nonoperating Expense (NNE)		 21 17 -233 52 12 31 19 21 22 35 18
Net Nonoperating Obligations (NNO)		 -140 -204 -266 -76 -79 -113 -187 -228 -279 -344 -283
Total Depreciation and Amortization (D&A)		 -3.38 -6.87 -1.23 1.31 0.20 -1.35 0.01 1.09 2.29 2.34 1.61
Debt-free, Cash-free Net Working Capital to Revenue		 -9,227.83% -3,755.56% -28.41% -427.39% -108.66% -36.82% -139.11% -182.09% -99.28% -108.49% -244.80%
Debt-free Net Working Capital to Revenue		 52,867.92% 52,675.00% 614.13% 4,037.85% 1,361.22% 869.60% 2,445.84% 3,189.52% 3,969.84% 1,938.84% 5,561.53%
Net Working Capital to Revenue		 52,867.92% 52,675.00% 614.13% 3,330.42% 1,361.22% 869.60% 2,445.84% 3,189.52% 3,969.84% 1,938.84% 5,455.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.99) ($0.93) $1.97 ($2.04) ($0.70) ($2.03) ($1.43) ($1.51) ($1.65) ($2.67) ($1.80)
Adjusted Weighted Average Basic Shares Outstanding		 89.70M 88.60M 87.56M 84.93M 85.68M 61.74M 50.90M 47.65M 46.56M 46.18M 41.09M
Adjusted Diluted Earnings per Share		 ($0.99) ($0.93) $1.94 ($2.04) ($0.70) ($2.03) ($1.43) ($1.51) ($1.65) ($2.67) ($1.80)
Adjusted Weighted Average Diluted Shares Outstanding		 89.70M 88.60M 88.78M 84.93M 85.68M 61.74M 50.90M 47.65M 46.56M 46.18M 41.09M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.70) ($2.03) ($1.43) ($1.51) ($1.65) ($2.67) ($1.80)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 93.80M 89.21M 88.27M 87.03M 62.18M 55.50M 48.59M 46.96M 46.27M 43.88M 33.00M
Normalized Net Operating Profit after Tax (NOPAT)		 -68 -65 -60 -121 -31 -81 -50 -50 -55 -83 -41
Normalized NOPAT Margin		 -31,885.33% -20,106.64% -178.49% -6,133.40% -580.07% -648.52% -694.62% -1,123.08% -956.97% -769.15% -1,019.96%
Pre Tax Income Margin		 -41,691.98% -25,337.96% 509.11% -8,753.71% -810.16% -899.24% -962.78% -1,579.53% -1,339.71% -1,090.62% -1,468.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -131.99
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -92.39
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -134.27
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -94.67
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -0.02% -0.58% -0.08% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Chimerix

This table displays calculated financial ratios and metrics derived from Chimerix's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 1,325.00% 136.36% 396.15% -100.00% -99.51% -99.97% -94.09% 1,786.67% 1,669.57% 30,325.23%
EBITDA Growth		 -12.33% 9.60% -3.23% 2.89% 12.47% -111.71% 0.70% -6.70% 35.43% 1,419.55%
EBIT Growth		 -17.98% 7.10% -6.95% -0.71% 12.61% -111.06% 8.95% 2.23% 39.76% 1,397.40%
NOPAT Growth		 -17.98% 7.10% -6.95% -0.71% 12.61% -260.52% 8.95% 2.23% 39.76% 189.39%
Net Income Growth		 -26.39% 4.62% -11.35% -2.33% 13.35% -109.94% 20.85% 13.71% 46.93% 1,400.44%
EPS Growth		 -19.05% 3.70% -9.52% -4.17% 19.23% -109.82% 22.22% 14.29% 36.59% 1,409.52%
Operating Cash Flow Growth		 -32.08% -14.36% -23.30% 21.18% 27.02% -351.59% -35.81% 5.21% 41.25% 146.62%
Free Cash Flow Firm Growth		 16.36% 54.02% 56.51% 46.87% 22.27% -227.18% -151.43% 2.17% 37.49% 238.34%
Invested Capital Growth		 -60.86% -91.70% -78.63% -143.95% -25.93% 16.71% 39.08% -8.12% -11.87% -73.60%
Revenue Q/Q Growth		 119.23% -79.85% 0.00% -100.00% -63.64% -57.69% -90.81% -65.23% -97.50% 7,298.86%
EBITDA Q/Q Growth		 2.34% -6.78% 6.08% -15.15% 21.40% -21.93% 11.65% -3.37% -110.52% 1,133.74%
EBIT Q/Q Growth		 0.97% -8.59% 6.39% -17.20% 22.03% -25.02% 11.85% -1.70% -109.87% 1,129.20%
NOPAT Q/Q Growth		 0.97% -8.59% 6.39% -17.20% 22.03% -25.02% 11.85% -1.70% -243.23% 170.91%
Net Income Q/Q Growth		 -0.33% -10.61% 5.41% -20.42% 24.29% -29.12% 13.08% -1.97% -108.68% 1,128.47%
EPS Q/Q Growth		 3.85% -13.04% 8.00% -19.05% 22.22% -28.57% 12.50% 7.69% -109.45% 1,118.52%
Operating Cash Flow Q/Q Growth		 6.05% -15.98% -0.94% -20.09% 18.65% -25.04% 35.47% -11.19% -380.42% 167.50%
Free Cash Flow Firm Q/Q Growth		 -8.74% -4.54% -2.34% 28.10% 40.23% 1.12% -25.03% -5.19% -197.78% 295.49%
Invested Capital Q/Q Growth		 -10.74% -4.71% -13.11% -22.65% -31.97% 2.43% -54.47% 36.69% 12.71% 28.64%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.98%
EBITDA Margin		 -43,792.98% -98,303.85% -18,555.81% 0.00% -555,575.00% -257,027.27% -89,184.62% -9,274.20% -3,119.16% 741.51%
Operating Margin		 -43,073.68% -95,357.69% -17,699.22% 0.00% -520,250.00% -242,627.27% -82,107.69% -8,557.60% -2,925.55% 35.77%
EBIT Margin		 -43,073.68% -95,357.69% -17,699.22% 0.00% -520,250.00% -242,627.27% -82,107.69% -8,557.60% -2,925.55% 741.26%
Profit (Net Income) Margin		 -40,270.18% -87,996.15% -16,034.88% 0.00% -454,025.00% -218,054.55% -71,446.15% -7,551.94% -2,574.94% 741.40%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.44% 99.94%
Interest Burden Percent		 93.49% 92.28% 90.60% 89.66% 87.27% 89.87% 87.02% 88.25% 88.51% 100.08%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -56.17% -48.59% -44.62% -39.86% -36.50% -35.21% 143.19% 121.87% 105.91% 81.17%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -50.90% -78.98% -12.15% 0.00% -685.05% -1,059.94% -18,769.67% -1,800.63% -520.97% 114.69%
Return on Assets (ROA)		 -47.59% -72.88% -11.01% 0.00% -597.84% -952.59% -16,332.46% -1,589.02% -458.54% 114.71%
Return on Common Equity (ROCE)		 -56.17% -48.59% -44.62% -39.86% -36.50% -35.21% 143.19% 121.87% 105.91% 81.17%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -61.57% -54.44% -47.44% 0.00% -40.76% 80.52% 73.06% 0.00% 56.08%
Net Operating Profit after Tax (NOPAT)		 -17 -17 -16 -17 -15 -19 -15 -17 -17 12
NOPAT Margin		 -30,151.58% -66,750.38% -12,389.46% 0.00% -364,175.00% -169,839.09% -57,475.38% -5,990.32% -2,047.89% 35.75%
Net Nonoperating Expense Percent (NNEP)		 -3.35% -2.99% -2.33% -2.21% -1.53% -2.12% -2.64% -2.95% -2.51% 116.32%
Return On Investment Capital (ROIC_SIMPLE)		 -14.12% - - - -7.55% - - - -6.49% -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.02%
SG&A Expenses to Revenue		 12,198.25% 19,896.15% 3,513.95% 0.00% 129,250.00% 84,581.82% 17,107.69% 2,006.71% 656.88% 16.32%
R&D to Revenue		 30,975.44% 75,561.54% 14,285.27% 0.00% 391,100.00% 158,145.45% 65,100.00% 6,650.88% 2,368.67% 46.88%
Operating Expenses to Revenue		 43,173.68% 95,457.69% 17,799.22% 0.00% 520,350.00% 242,727.27% 82,207.69% 8,657.60% 3,025.55% 63.20%
Earnings before Interest and Taxes (EBIT)		 -25 -25 -23 -24 -21 -27 -21 -24 -24 241
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -25 -26 -24 -25 -22 -28 -23 -26 -25 241
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.57 0.61 0.50 0.54 0.44 0.41 0.48 0.46 0.64 0.62
Price to Tangible Book Value (P/TBV)		 2.57 0.61 0.50 0.54 0.44 0.41 0.48 0.46 0.64 0.62
Price to Revenue (P/Rev)		 1,476.31 524.30 545.25 2,306.41 264.07 74.98 3.18 3.26 4.84 5.12
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.59 0.63 0.95 1.10
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 168.36% 157.84% 105.13% 90.84%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 815.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.10 -1.07 -1.07 -1.05 -1.05 -1.04 -1.09 -1.04 -1.05 -1.04
Leverage Ratio		 1.14 1.12 1.11 1.09 1.09 1.08 1.17 1.12 1.17 1.13
Compound Leverage Factor		 1.07 1.03 1.00 0.98 0.95 0.97 1.02 0.99 1.03 1.13
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.91%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.76
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.74
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.39 -5.03 -4.06 -2.58 -1.99 -1.23 0.24 0.47 1.53 5.73
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 5.70 6.33 6.94 8.61 10.25 12.94 13.79 13.68 11.18 16.44
Quick Ratio		 5.52 6.13 6.71 8.40 9.91 12.54 13.41 13.11 10.70 16.10
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -10 -9.39 -8.98 -8.78 -12 -20 -21 -17 -16 16
Operating Cash Flow to CapEx		 -11,820.86% -78,876.92% -24,905.63% -64,881.48% 0.00% -119,553.33% -119,516.67% -35,846.77% 0.00% 9,900.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.23 0.21 0.18 0.15
Accounts Receivable Turnover		 6.95 1.92 1.86 0.12 0.62 4.73 0.00 0.00 0.00 126.89
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.66 0.60 0.54 0.15 1.44 4.54 146.11 137.47 140.93 128.12
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.11 0.15 0.18
Days Sales Outstanding (DSO)		 52.51 190.53 196.44 2,977.87 588.06 77.09 0.00 0.00 0.00 2.88
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 1,954.34 3,475.17 2,376.99 2,071.60
Cash Conversion Cycle (CCC)		 52.51 190.53 196.44 2,977.87 588.06 77.09 -1,954.34 -3,475.17 -2,376.99 -2,068.72
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -18 -17 -16 -14 -11 -8.69 -8.90 -5.76 -9.10 -10
Invested Capital Turnover		 -0.01 -0.01 -0.01 0.00 -0.03 -0.12 -2.86 -6.15 -3.92 -4.02
Increase / (Decrease) in Invested Capital		 -6.98 -7.97 -7.00 -8.30 -2.36 1.74 5.71 -0.43 -0.97 -4.42
Enterprise Value (EV)		 173 -69 -93 -94 -119 -132 -126 -135 -102 -115
Market Capitalization		 313 83 79 95 86 85 107 111 164 169
Book Value per Share		 $1.35 $1.51 $1.74 $1.95 $2.17 $2.35 $2.53 $2.72 $2.92 $3.13
Tangible Book Value per Share		 $1.35 $1.51 $1.74 $1.95 $2.17 $2.35 $2.53 $2.72 $2.92 $3.13
Total Capital		 122 136 156 174 193 208 224 240 257 274
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25
Net Debt		 -140 -152 -171 -188 -204 -217 -233 -246 -266 -284
Capital Expenditures (CapEx)		 0.16 0.03 0.07 0.03 -0.00 0.02 0.01 0.06 -0.00 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -20 -18 -17 -15 -12 -9.36 -9.58 -6.43 -9.61 -11
Debt-free Net Working Capital (DFNWC)		 112 119 131 144 171 185 196 208 208 273
Net Working Capital (NWC)		 112 119 131 144 171 185 196 208 208 273
Net Nonoperating Expense (NNE)		 5.77 5.52 4.70 4.80 3.59 5.30 3.63 4.42 4.29 -230
Net Nonoperating Obligations (NNO)		 -140 -152 -171 -188 -204 -217 -233 -246 -266 -284
Total Depreciation and Amortization (D&A)		 -0.41 -0.77 -1.11 -1.10 -1.41 -1.58 -1.84 -2.03 -1.58 0.08
Debt-free, Cash-free Net Working Capital to Revenue		 -9,227.83% -11,051.57% -11,677.78% -36,417.07% -3,755.56% -825.66% -28.45% -18.87% -28.41% -33.94%
Debt-free Net Working Capital to Revenue		 52,867.92% 74,627.67% 91,217.36% 351,456.10% 52,675.00% 16,323.81% 582.50% 611.05% 614.13% 827.11%
Net Working Capital to Revenue		 52,867.92% 74,627.67% 91,217.36% 351,456.10% 52,675.00% 16,323.81% 582.50% 611.05% 614.13% 827.11%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.25) ($0.26) ($0.23) ($0.25) ($0.21) ($0.27) ($0.21) ($0.24) ($0.23) $2.75
Adjusted Weighted Average Basic Shares Outstanding		 89.70M 89.70M 89.63M 89.26M 88.60M 88.62M 88.58M 88.29M 87.56M 87.63M
Adjusted Diluted Earnings per Share		 ($0.25) ($0.26) ($0.23) ($0.25) ($0.21) ($0.27) ($0.21) ($0.24) ($0.26) $2.75
Adjusted Weighted Average Diluted Shares Outstanding		 89.70M 89.70M 89.63M 89.26M 88.60M 88.62M 88.58M 88.29M 88.78M 87.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 93.80M 89.94M 89.64M 89.63M 89.21M 88.89M 88.58M 88.58M 88.27M 88.05M
Normalized Net Operating Profit after Tax (NOPAT)		 -17 -17 -16 -17 -15 -19 -15 -17 -17 12
Normalized NOPAT Margin		 -30,151.58% -66,750.38% -12,389.46% 0.00% -364,175.00% -169,839.09% -57,475.38% -5,990.32% -2,047.89% 35.75%
Pre Tax Income Margin		 -40,270.18% -87,996.15% -16,034.88% 0.00% -454,025.00% -218,054.55% -71,446.15% -7,551.94% -2,589.31% 741.87%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Chimerix's Financials

When does Chimerix's financial year end?

According to the most recent income statement we have on file, Chimerix's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Chimerix's net income changed over the last 10 years?

Chimerix's net income appears to be on a downward trend, with a most recent value of -$88.39 million in 2024, rising from -$59.31 million in 2014. The previous period was -$82.10 million in 2023. Find out what analysts predict for Chimerix in the coming months.

What is Chimerix's operating income?
Chimerix's total operating income in 2024 was -$96.57 million, based on the following breakdown:
  • Total Gross Profit: $212 thousand
  • Total Operating Expenses: $96.78 million
How has Chimerix revenue changed over the last 10 years?

Over the last 10 years, Chimerix's total revenue changed from $4.04 million in 2014 to $212 thousand in 2024, a change of -94.8%.

How much debt does Chimerix have?

Chimerix's total liabilities were at $24.33 million at the end of 2024, a 23.2% increase from 2023, and a 41.1% increase since 2014.

How much cash does Chimerix have?

In the past 10 years, Chimerix's cash and equivalents has ranged from $15.40 million in 2021 to $128.46 million in 2014, and is currently $31.05 million as of their latest financial filing in 2024.

How has Chimerix's book value per share changed over the last 10 years?

Over the last 10 years, Chimerix's book value per share changed from 7.53 in 2014 to 1.35 in 2024, a change of -82.0%.


Related Companies

This page (NASDAQ:CMRX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored